Printer Friendly
The Free Library
14,717,777 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Kobayashi Pharmaceutical Confirms That Eucommia Ulmoies Helps Improve Metabolic Syndrome.


Tokyo, Japan, Apr 5, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
) - Kobayashi Pharmaceutical has announced the results of its recent research on eucommia ulmoies, a kind of Chinese herbal tea.

According to according to
prep.
1. As stated or indicated by; on the authority of: according to historians.

2. In keeping with: according to instructions.

3.
 the company, eucommia ulmoies helps improve metabolic syndrome metabolic syndrome
n.
See syndrome X.


Metabolic syndrome
A group of risk factors for heart disease, diabetes, and stroke.
. In a mice experiment conducted with the Mie University Mie University was founded on May 31, 1949 with two faculties: Liberal Arts and Agriculture. These gave way to the establishment's present composition of six faculties: Humanities, Medicine, Education, Bioresources, Engineering and Common Education - the latter dealing with cross-faculty  Faculty of Medicine, the company has confirmed that eucommia ulmoies inhibits the accumulation of visceral fat. Further, it has a property to increase the blood adiponectin levels and improve the ability to utilize glucose.

The company plans to verify these findings in clinical research with human subjects. Details of the above findings were presented at the 126th Annual Meeting of the Pharmaceutical society of Japan held in Sendai on March 30.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Apr 5, 2006
Words:125
Previous Article:National Institute of Advanced Industrial Science and Technology (AIST) Elucidates Ultra-Sensitive Detection of Trace Amounts of Proteins Using...
Next Article:Alfresa Pharma, Tanabe Seiyaku to Collaborate in Development and Sales of Narcolepsy Drug Modafinil.



Related Articles
Kobayashi Pharmaceutical Announces Results for the Third Quarter Ended December 31, 2005.
Kanebo Develops Kampo Medicine-based Detoxification Method.
Medical maverick Tsuneo Kobayashi: a forerunner of cancer treatment and prevention.
Meniere's syndrome, otosclerosis, and insulin resistance syndrome.(VESTIBULOLOGY CLINIC)
Asahi Soft Drinks, Others Find Vanadium in Water May Help Diabetes.
Kobayashi Pharmaceutical Sets up New Subsidiary in Germany.
Kobayashi Pharmaceutical Reports Financial Results for the Year Ended March 31, 2006.
From the editor.(Editorial)
Kobayashi Pharmaceutical Reports Financial Results for the First Quarter Ended June 30, 2006.
Women & metabolic syndrome.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles